Benzinga’s Top Pre- Market Losers (CADC, TIBX, PARD, HGSI, SHPGY, ATVI)

China Advanced Const. Mat. Grp Inc (OTC: CADC) plunged 23.20% to $5 in the pre-market session. The 52 week trading range for CADC is $1.01 -$8.50. So far this fiscal, CADC gained 5%. In the last trading session, China Advanced Const. Mat. Grp Inc (OTC: CADC) closed at $6.51.

Tibco Software Inc. (NASDAQ: TIBX) plummeted 2.56% to $9.14 after Goldman Sachs downgraded TIBX from $9.50 to $9. So far this year, TIBX is up 80.73%.

Poniard Pharmaceuticals, Inc. (NASDAQ: PARD) decreased $5.88 or 77% to $1.69 after PARD failed to meet its primary end point of pivotal Phase 3 SPEAR trial Of picoplatin. In the last trading session, PARD ended at $7.58.

Human Genome Sciences (NASDAQ: HGSI) declined 1.04% or $0.29 to $27.60 in the pre-market session after The U.S. health regulators denied approval to Human Genome’s anthrax drug raxibacumab. So far this year, HGSI is up over 1215%.

Shire Plc. (ADR) (NASDAQ: SHPGY) fell 1.82 or $1.09 to $58.71. The 52 week trading range for SHPGY is $31.66 - $60.32. SHPGY closed at $59.80 in the previous trading session.

Activision Blizzard, Inc. (NASDAQ: ATVI) declined 0.09% in the pre-market session and currently trades at $11.68. In the current fiscal, ATVI gained around 35%.